Net revenue and net profit grew year-over-year in H1 2025, supported by strong operating cash flow, robust segment performance across regions, and ongoing hospital expansion. The group maintained high liquidity, low leverage, and distributed a significant cash dividend.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.